Literature DB >> 17194573

The economic burden of depression in Sweden from 1997 to 2005.

Patrik Sobocki1, Ingrid Lekander, Fredrik Borgström, Oskar Ström, Bo Runeson.   

Abstract

BACKGROUND: Depression is one of the most common causes of disability and is associated with substantial reductions in the individual's quality of life. The aim of this study was to estimate the economic burden of depression to Swedish society from 1997 to 2005.
MATERIALS AND METHODS: The study was conducted in a cost-of-illness framework, measuring both the direct cost of providing health care to depressive patients, and the indirect costs as the value of production that is lost due to morbidity or mortality. The costs were estimated by a prevalence and top-down approach.
RESULTS: The cost of depression increased from a total of 1.7 billion euros in 1997 to 3.5 billion euros in 2005, representing a doubling of the burden of depression to society. The main reason for the cost increase is found in the significant increase in indirect costs due to sick leave and early retirement during the past decade, whereas direct costs were relatively stable over time. In 2005, indirect costs were estimated at 3 billion euros (86% of total costs) and direct costs at 500 million euros (16%). Cost of drugs was estimated at 100 million euros (3% of total cost).
CONCLUSION: The cost of depression is substantial to society and the main cost driver is indirect costs due to sick leave and early retirement. The cost of depression has doubled during the past eight years making it a major public health concern for the individuals afflicted, carers and decision makers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194573     DOI: 10.1016/j.eurpsy.2006.10.006

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  37 in total

1.  Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.

Authors:  F Borgström; O Ström; M Kleman; E McCloskey; H Johansson; A Odén; J A Kanis
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

2.  Incarcerating juveniles in adult prisons as a factor in depression.

Authors:  Irene Y H Ng; Xiaoyi Shen; Helen Sim; Rosemary C Sarri; Elizabeth Stoffregen; Jeffrey J Shook
Journal:  Crim Behav Ment Health       Date:  2011-02

3.  Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm.

Authors:  K Kim; A Svedbom; X Luo; S Sutradhar; J A Kanis
Journal:  Osteoporos Int       Date:  2013-10-10       Impact factor: 4.507

4.  Working conditions and psychotropic medication: a prospective cohort study.

Authors:  Mikko Laaksonen; Tea Lallukka; Eero Lahelma; Timo Partonen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-29       Impact factor: 4.328

5.  The recognition of mental health disorders and its association with psychiatric scepticism, knowledge of psychiatry, and the Big Five personality factors: an investigation using the overclaiming technique.

Authors:  Viren Swami; Raj Persaud; Adrian Furnham
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-02-06       Impact factor: 4.328

6.  The impact of psychiatric disorders on employment: results from a national survey (NESARC).

Authors:  Inger Burnett-Zeigler; Mark A Ilgen; Kipling Bohnert; Erin Miller; Khairul Islam; Kara Zivin
Journal:  Community Ment Health J       Date:  2012-03-27

7.  Cost of depression among adults in Japan.

Authors:  Yasuyuki Okumura; Teruhiko Higuchi
Journal:  Prim Care Companion CNS Disord       Date:  2011

8.  Psychosocial working conditions and depressive symptoms among Swedish employees.

Authors:  Linda L Magnusson Hanson; Töres Theorell; Per Bech; Reiner Rugulies; Hermann Burr; Martin Hyde; Gabriel Oxenstierna; Hugo Westerlund
Journal:  Int Arch Occup Environ Health       Date:  2009-02-24       Impact factor: 3.015

9.  Deteriorating health status in Stockholm 1998-2002: results from repeated population surveys using the EQ-5D.

Authors:  Kristina Burström; Magnus Johannesson; Clas Rehnberg
Journal:  Qual Life Res       Date:  2007-09-09       Impact factor: 4.147

10.  Clinical validity of a population database definition of remission in patients with major depression.

Authors:  Antoni Sicras-Mainar; Milagrosa Blanca-Tamayo; Laura Gutiérrez-Nicuesa; Jordi Salvatella-Pasant; Ruth Navarro-Artieda
Journal:  BMC Public Health       Date:  2010-02-11       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.